Thrivent Financial For Lutherans Fibrogen Inc Transaction History

Thrivent Financial For Lutherans

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 17, 2023	BUY	$15.95 - $25.18 $892,593 - $1.41 Million	55,962 New	55,962 $1.04 Million
Q4 2018 Feb 15, 2019	SELL	$37.97 - $60.16 $596,129 - $944,512	-15,700 Closed	0 $0
Q3 2018 Nov 15, 2018	SELL	$56.3 - $67.25 $181,905 - $217,284	-3,231 Reduced 17.07%	15,700 $954,000
Q1 2018 May 08, 2018	BUY	$45.35 - $61.65 $858,520 - $1.17 Million	18,931 New	18,931 $874,000

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

Stay updated on Thrivent Financial For Lutherans with notifications on news.